Relative to NSCLC with fusion rearrangements, a lower frequency of pleural metastases and lymphangitic carcinomatosis have been reported in G12C KRAS mutant lung cancers; brain and soft tissue metastases are, however, more common. The gene discussed is KRAS; the disease is lung carcinoma.